Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Pain, Postoperative 9Breast Neoplasms 6Brain Neoplasms 6Neoplasms 4Lung Neoplasms 4Thyroid Neoplasms 3Agnosia 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Rectal Neoplasms 2Prostatic Neoplasms 2Pheochromocytoma 2Neoplasm Metastasis 2Liver Neoplasms 2Dexmedetomidine 2Colonic Neoplasms 2Chronic Pain 2Supratentorial Neoplasms 1Sleep Initiation and Maintenance Disorders 1Sigmoid Neoplasms 1Seizures 1Prostatic Hyperplasia 1Postoperative Nausea and Vomiting 1Postoperative Analgesia 1Pneumoperitoneum 1Pancreatic Neoplasms 1Pain, Intractable 1Obesity 1Neuroinflammatory Diseases 1Neurofibromatoses 1

Interventions

gadobenic acid 2Cancer Vaccines 2Adjuvants, Immunologic 2veliparib 1tipifarnib 1interferon gamma-1b 1glutathione pegylated liposomal doxorubicin 1gadoteridol 1Trastuzumab 1Temozolomide 1Sodium Chloride 1Oncolytic Virotherapy 1Interferon-gamma 1Immunotherapy 1Dexmedetomidine 1Craniotomy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Central Nervous System Diseases × Dexmedetomidine × Clear all
NCT04494828 2021-01-12

Impact Dexmedetomidine on Postoperative Delirium in Patients After Intracranial Operation for Brain Tumor

Capital Medical University

Phase 4 Completed
60 enrolled
CNS

Central Nervous System Diseases, Delirium

Data powered by HemOnc (CC BY 4.0) Colophon âš¡